Jason Moore, M.S.,M.B.A.
Vice President

Jason has a decade of biotech industry experience, having managed a spectrum of new-drug development and registration activities for both established and emerging biotechnology companies. Jason's drug development experience includes both small molecule and biological therapeutics and spans preclinical and CMC related projects, domestic and international clinical trials, major and minor regulatory submissions, financial modeling and strategic alliances. Prior to his move to PLx Pharma, Jason was director of industry programs at BioHouston, where he was responsible for a range of programs to accelerate Houston's emergence as a top biotechnology cluster. Among the previous companies for which Jason has worked are Amgen, Antigenics, Aronex Pharmaceuticals, and Introgen Therapeutics. Jason has also been a consultant in regulatory affairs, strategy, and medical writing for biotechnology companies and academic research labs engaged in new drug development. He earned an M.S. in Science and Technology Journalism from Texas A&M University and an M.B.A. from the C. T. Bauer College of Business at the University of Houston.